Literature DB >> 31332920

Application of the H2 FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial.

Peder L Myhre1,2, Muthiah Vaduganathan1, Brian L Claggett1, Carolyn S P Lam3, Akshay S Desai1, Inder S Anand4, Nancy K Sweitzer5, James C Fang6, Eileen O'Meara7, Sanjiv J Shah8, Amil M Shah1, Eldrin F Lewis1, Jean Rouleau7, Bertram Pitt9, Scott D Solomon1.   

Abstract

Entities:  

Year:  2019        PMID： 31332920      PMCID： PMC6819199          DOI： 10.1002/ejhf.1542

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  8 in total

1.  A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Rickey E Carter; Masaru Obokata; Margaret M Redfield; Barry A Borlaug
Journal:  Circulation       Date:  2018-08-28       Impact factor: 29.690

2.  Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Matthew W Segar; Kershaw V Patel; Jarett D Berry; Justin L Grodin; Ambarish Pandey
Journal:  Circulation       Date:  2019-04-09       Impact factor: 29.690

3.  External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Nariman Sepehrvand; Wendimagegn Alemayehu; Garrison J B Dyck; Jason R B Dyck; Todd Anderson; Jonathan Howlett; Ian Paterson; Finlay A McAlister; Justin A Ezekowitz
Journal:  Circulation       Date:  2019-05-14       Impact factor: 29.690

4.  Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Authors:  Marc A Pfeffer; Brian Claggett; Susan F Assmann; Robin Boineau; Inder S Anand; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; John F Heitner; Eldrin F Lewis; Eileen O'Meara; Jean-Lucien Rouleau; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Sonja M McKinlay; Bertram Pitt
Journal:  Circulation       Date:  2014-11-18       Impact factor: 29.690

5.  Spironolactone for heart failure with preserved ejection fraction.

Authors:  Bertram Pitt; Marc A Pfeffer; Susan F Assmann; Robin Boineau; Inder S Anand; Brian Claggett; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Brian Harty; John F Heitner; Christopher T Kenwood; Eldrin F Lewis; Eileen O'Meara; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Song Yang; Sonja M McKinlay
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

6.  Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.

Authors:  Stephen J Greene; Adrian F Hernandez; Jie-Lena Sun; Javed Butler; Paul W Armstrong; Justin A Ezekowitz; Faiez Zannad; João Pedro Ferreira; Adrian Coles; Marco Metra; Adriaan A Voors; Robert M Califf; Christopher M O'Connor; Robert J Mentz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-10

7.  Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.

Authors:  Peder Langeland Myhre; Muthiah Vaduganathan; Brian L Claggett; Inder S Anand; Nancy K Sweitzer; James C Fang; Eileen O'Meara; Sanjiv J Shah; Akshay S Desai; Eldrin F Lewis; Jean Rouleau; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  JAMA Cardiol       Date:  2018-10-01       Impact factor: 14.676

8.  Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Authors:  Amil M Shah; Sanjiv J Shah; Inder S Anand; Nancy K Sweitzer; Eileen O'Meara; John F Heitner; George Sopko; Guichu Li; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2013-11-18       Impact factor: 8.790
  8 in total
  4 in total

Review 1.  Heart failure with preserved ejection fraction update: A review of clinical trials and new therapeutic considerations.

Authors:  Andrii Maryniak; Nodari Maisuradze; Rafsan Ahmed; Patrick Biskupski; Joseph Jayaraj; Adam S Budzikowski
Journal:  Cardiol J       Date:  2022-06-28       Impact factor: 3.487

Review 2.  Evaluation and management of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

Review 3.  Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models.

Authors:  Coenraad Withaar; Carolyn S P Lam; Gabriele G Schiattarella; Rudolf A de Boer; Laura M G Meems
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 29.983

Review 4.  Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction.

Authors:  Alberico Del Torto; Andrea Igoren Guaricci; Francesca Pomarico; Marco Guglielmo; Laura Fusini; Francesco Monitillo; Daniela Santoro; Monica Vannini; Alexia Rossi; Giuseppe Muscogiuri; Andrea Baggiano; Gianluca Pontone
Journal:  Front Cardiovasc Med       Date:  2022-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.